Antituberculosis
Introduction
Tuberculosis (TB) is a global pandemic caused by Mycobacterium tuberculosis [1, 2] . Globally, there are an estimated 9.3 million new cases and 13.7 million chronic active cases responsible for 1.7 million deaths worldwide yearly. About one-third of the world's population is at risk to develop active TB and contribute to the continued spread of M. tuberculosis http://dx.doi.org/10.1016/j.ijmyco.2015.08.004 2212-5531/Ó 2015 Asian African Society for Mycobacteriology. Production and hosting by Elsevier Ltd. All rights reserved. within communities [3] [4] [5] . While TB itself has historically been of central concern of public health and infectious diseases, the last few decades have witnessed the rise of human immunodeficiency virus/AIDS, an immunosuppressive illness that amplifies the infectivity of the tubercle bacillus and catalyzes its conversion from latent to active infection [6] . Furthermore, the emergence of M. tuberculosis strains resistant to conventional first-line and second-line antitubercular treatment is particularly worrisome [7, 8] , since no new anti-TB drugs have been introduced into the market since 1967. Moreover, up to 50 million people are infected with drug-resistant forms of TB with about 500,000 cases of multidrug-resistant TB a year worldwide [9] . Even though there are currently new lead compounds being characterized for TB treatment [10, 11] , they are challenged by poor accessibility, high costs, long treatment regimen, and low adherence owing to the toxicity of secondline drugs. The newly commercialized drug is likely to be exhausted with the emerging resistance, emphasizing the imperative continuous search, identification, and characterization of more compounds for anti-TB drugs.
Medicinal plants have been used for centuries as nonexhaustive sources of metabolites for drug development and as an alternative remedy for treating human diseases, as they contain numerous active constituents of therapeutic value [12] [13] [14] [15] . Rational chemistry, while essential to the development of many modern pharmaceuticals, often serves better to refine the chemical blueprints isolated from natural product screens than to devise entirely new molecular backbones. The enormous diversity of plant-derived compounds therefore makes them one of the most promising reservoirs of potentially novel anti-TB molecules. Cameroon is renowned for its rich and uncharacterized biodiversity [16] , and Cameroonian medicinal plants are frequently used to treat diseases as a means of reducing reliance on expensive imported and/or chemical drugs. Such plants should be identified and screened on the basis of traditional knowledge for efficacy in the treatment of TB.
This work reports on the in vitro anti-TB evaluation of medicinal plants identified during an ethnobotanical survey carried out in Kala at the Department of ''Mé fou-et-Akono"/C entre Region and in Dschang at the Menoua Department/West Region. This survey investigated on medicinal plants used by traditional healers to treat cough and pulmonary diseases.
Materials and methods

Plant collection and conditioning
Plants (bark, roots, and stalk) were collected based on the information obtained from traditional healers from Kala at the Department of ''Mé fou-et-Akono"/Centre Region and in Dschang at the Menoua Department/West Region of Cameroon. In Cameroon, generally, most people rely on traditional healers for their primary health care. These traditional healers used plants to treat persisting cough and chest pain. They have inherited the knowledge from their parents, grandparents, and ancestors.
The collected plants were identified at the National Herbarium of Yaoundé , where voucher-specimen numbers were obtained. Figs. 1 and 2 are photographs of two of the plants used (Garcinia preussei and Acanthus montanus). The plant material was dried and ground into coarse or fine powder depending on their texture.
Preparation of plant extract
Crude extracts of plant parts were prepared as follows:
1. For hot extraction, 40 g of the powdered bark or stalk was weighed and put into the extraction thimble on the Soxhlet to which 250 mL of the solvent was added. The various solvents used were methanol, hexane, and ethyl acetate. The Soxhlet was switched on and extraction was carried out for 2 h and 30 min. The solvent was removed from the extract by evaporation on a rotavapor. 2. For cold extraction, 100 g of powdered roots or stalk was weighed and added into 500 mL of the solvent. Extraction was carried out at room temperature with frequent shaking for 48 h. The filtrates were evaporated to dryness using the rotavapor.
The obtained crude extracts were thus stored at 4°C for subsequent work. The phytochemical screening of the plant extracts was carried out by the method described by Harborne [17] .
In vitro anti-TB screening
M. tuberculosis culture preparation
The M. tuberculosis reference strain, H37Rv, was used. Ten milliliters of Middlebrook 7H9 broth supplemented with 10% oleic acid-albumin-dextrose-catalase and 0.2% of glycerol culture was inoculated with 0.4-0.6 mL of freezer stock of H37Rv in a 50 mL conical tube. The culture was grown to mid-log phase on the wheel at 37°C, until OD 600 = 0.4-0.8. Using 7H9 broth without Tween 80, the culture was diluted to OD 600 = 0.001. This resulted in a culture with approximately 10 5 CFU/mL. Then, 100 lL of this culture was used to set up the assay plates, with each well containing 10 4 CFU.
Antimycobacterial-activity tests
The antimycobacterial activity of the plant crude extracts was tested using the microplate alamarBlue assay [18, 19] .
Fig. 1 -Leaves of Garcinia preussii.
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The susceptibility test was done in 96 microtiter plates using the alamarBlue reagent as an indicator of cellular viability. Working solutions of the tested extracts were diluted in Middlebrook 7H9 broth supplemented with oleic acidalbumin-dextrose-catalase to obtain the final sample concentrations that ranged from 250 lg/mL to 31.25 lg/mL. Isoniazid was dissolved in dimethyl sulfoxide and used as a positive control drug at 1.28 lg/mL as the starting concentration, and extracts/drug-free medium with strain suspensions were used as the negative control. One hundred microliter of 7H9 broth were added into all wells of the 96-well plate, and 100 lL of the compounds/extracts was introduced to the wells in the first row (A) and mixed thoroughly. The sample mixture (100 lL) was removed from wells of row A to perform a twofold serial dilution down the rows (B-H). The last 100 lL was discarded. Then, 100 lL of the inoculum was introduced into the corresponding wells. The final volume in each well was 200 lL. Each extract concentration was assayed in duplicate. Each microplate was then sealed with the optical sealing tape and incubated for 7 days at 37°C in normal atmosphere. After the incubation period, 32.5 lL of alamarBlue was added to each well. The plates were then reincubated for 16-18 h at 37°C in the dark.
The experimental results were computerized using the BMG, Leicester, United Kingdom OPTIMA microplate reader at 544ex/590em for data analysis.
The minimal-inhibitory-concentration (MIC) results were presented as mean value. The lowest concentration that resulted to 90% inhibition was defined as the MIC. The MIC values determined by this method were cross-checked using the broth-dilution methods. A blue color in the well was scored as ''no mycobacterial growth," and a pink color was scored as ''growth occurrence" [20, 21] . Table 1 presents the identification of the six studied plants, by scientific and family names, traditional usage, and voucherspecimen number. These plants belong to the following families: Annonaceae, Vitaceae, Rubiaceae, Urticaceae, Lauraceae, and Acanthaceae.
Results
Plants collected
Crude-extract preparation
Six different crude extracts were prepared with different solvents of extraction. The plant parts analyzed, the solvents used, and the yields of extraction are presented in Table 2 .
Antimycobacterial activity
The antimycobacterial activity of the plant crude extracts has been evaluated on the virulent strain H37Rv at the highest concentration of 250 lg/mL. The six tested extracts, namely, A. montanus, Beilschmiedia obscura, Cissus petiolata, Enantia chlorantha, Urera repens, and Garcinia preussii, were active against M. tuberculosis with MICs ranging from 31.25 lg/mL to 250 lg/mL. These results are summarized in Table 3 .
The most active anti-TB effect was obtained from the methanolic extract of B. obscura with an MIC of 31.25 lg/mL that inhibits the growth of M. tuberculosis at 96.2%. The methanolic extract of A. montanus and U. repens each exhibited an antimycobacterial activity with an MIC of 62.5 lg/mL and a percentage of growth inhibition of 95.06% and 98.4%, respectively.
Phytochemical screening of the plant extracts
The screens identified various compounds from the plant extracts. These compounds include phenols, sterols, saponins, flavonoids, and glycosides. These results are presented in Table 4 for each plant.
Discussion
Beilschmiedia species are known to produce many types of phytochemicals [22] [23] [24] with various biological activities. Besides, Fankam, Kuiate, and Kuete [25] worked on fruits of B. obscura, and found that they were highly active against a panel of Gram-negative bacteria.
Plants from the Acanthaceae family are widely used traditionally for the treatment of various ailments, such as infectious diseases [26, 27] . The antimycobacterial activity observed from Acanthus montanus corroborated with the study of Ikezu, Ajiwe, Ilozue, and Chukwukanne [28] , who worked on the leaves of A. montanus. They found that, in comparison with the activity of some standard antibiotics, the leaves of A. montanus were more active against Gram-negative and Gram-positive bacteria.
The roots of G. preussei displayed an MIC of 125 lg/mL on the virulent strain H37Rv. The biological activity of compounds isolated from Garcinia on Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Enterococcus faecalis has already been evaluated and shows interesting activities [29] . Kaikabo and Eloff [30] isolated two biflavonoids from Garcinia, and found that they were active against fast-growing and nonpathogenic Mycobacterium smegmatis, and had a good activity against nosocomial bacteria.
Although no antibacterial activity has yet been evaluated on C. petiolata, a plant belonging to the Vitaceae family, Garima, Saurabh, and Nagori [31] did an overview on the The symbol ''+" means ''present," while the symbol ''À" means ''absent".
I n t e r n a t i o n a l J o u r n a l o f M y c o b a c t e r i o l o g y 4 ( 2 0 1 5 ) 3 0 6 -3 1 1 pharmacological and therapeutic activity of Cissus quadrangularis, a plant from the same family. They reported that two asymmetrical tetracyclic triterpenoids and calcium were identified as its major constituents, and that it possesses antibacterial and antifungal activities [32] [33] [34] [35] . Moreover, the phytochemical study of the aerial part of C. quadrangularis done by Ruskin et al. [15] showed the presence of alkaloids, tannins, and flavonoids. These wide variety of phytochemical compounds could justify the antimycobacterial activity observed with C. petiolata. The investigation of E. chlorantha stem barks showed that they contained a large quantity of phenols, alkaloids, saponins, flavonoids, and glycosides [36, 37] . In addition, several reports in the literature indicate a wide variety of pharmacological activities of this plant [38, 39] . This can justify the observed antimycobacterial activity.
The stalk of U. repens showed an interesting activity with an MIC of 62.5 lg/mL. To the best of our knowledge, the antimycobacterial activity of this plant is being reported here for the first time. Nevertheless, according to Gindri et al. [40] , the leaves of Urera baccifera, a plant from the same genus Urera, inhibited the growth of Klebsiella pneumoniae, a Gram-negative bacterium.
It is worth pointing out that the activities showed from the plants studied are those from crude and unpurified, thus nonconcentrated, compounds. It is expected that fractionation of these crude extracts will improve the MIC observed.
Conclusion
The obtained results confirm and validate the traditional use of some of these plants, which could be good sources and alternative of metabolites for anti-TB-drug development. These encouraging results prompted us to pursue the evaluation of the most active extracts. Therefore, fractionation and further phytochemical and pharmacological studies of these plants are evidently worthy, and our group is focusing on this effort.
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